Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G W Carter

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
Biochemistry|January 10, 1989
Tertiary structure of human complement component C5a in solution from nuclear magnetic resonance dataE R Zuiderweg, D G Nettesheim, K W Mollison, et al.
The Journal of Applied Psychology|August 25, 2001
A synthetic validity approach to testing differential prediction hypothesesJ W Johnson, G W Carter, H K Davison, et al.
The Journal of Pharmacy and Pharmacology|January 1, 1982
Measurement of inflammatory reactions by a dye dilution methodG W Carter, P R Young, M K Martin, et al.
Research Communications in Chemical Pathology and Pharmacology|February 1, 1982
The effects of anti-inflammatory and other agents on the rat dermal arthus reactionG W Carter, M K Martin, R A Krause, et al.
Prostaglandins|May 1, 1985
Purification of a mammalian 5-lipoxygenase from rat basophilic leukemia cellsA M Goetze, L Fayer, J Bouska, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|December 1, 1974
Experimental antiinflammatory and analgesic studies with 3-trifluoromethyl-s-triazolo (3,4-a)-isoquinolineP R Young, P W Dodge, G W Carter, et al.
Proteins|January 1, 1988
Comparison of model and nuclear magnetic resonance structures for the human inflammatory protein C5aE R Zuiderweg, J Henkin, K W Mollison, et al.
Gene|January 1, 1986
High-level expression of a gene encoding the human complement factor C5a in Escherichia coliW Mandecki, B S Powell, K W Mollison, et al.
Journal of Pharmaceutical Sciences|August 1, 1990
Inhibitors of immune complex-induced inflammation: 5-substituted 3-[1-(2-benzoxazolyl)hydrazino]propanenitrile derivativesK H Kim, Y C Martin, P R Young, et al.
International Journal of Immunopharmacology|February 1, 1995
Clinical activity of leukotriene inhibitorsR R Harris, G W Carter, R L Bell, et al.
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Biochemistry|January 10, 1989
Tertiary structure of human complement component C5a in solution from nuclear magnetic resonance dataE R Zuiderweg, D G Nettesheim, K W Mollison, et al.
The Journal of Applied Psychology|August 25, 2001
A synthetic validity approach to testing differential prediction hypothesesJ W Johnson, G W Carter, H K Davison, et al.
The Journal of Pharmacy and Pharmacology|January 1, 1982
Measurement of inflammatory reactions by a dye dilution methodG W Carter, P R Young, M K Martin, et al.
Research Communications in Chemical Pathology and Pharmacology|February 1, 1982
The effects of anti-inflammatory and other agents on the rat dermal arthus reactionG W Carter, M K Martin, R A Krause, et al.
Prostaglandins|May 1, 1985
Purification of a mammalian 5-lipoxygenase from rat basophilic leukemia cellsA M Goetze, L Fayer, J Bouska, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|December 1, 1974
Experimental antiinflammatory and analgesic studies with 3-trifluoromethyl-s-triazolo (3,4-a)-isoquinolineP R Young, P W Dodge, G W Carter, et al.
Proteins|January 1, 1988
Comparison of model and nuclear magnetic resonance structures for the human inflammatory protein C5aE R Zuiderweg, J Henkin, K W Mollison, et al.
Gene|January 1, 1986
High-level expression of a gene encoding the human complement factor C5a in Escherichia coliW Mandecki, B S Powell, K W Mollison, et al.
Journal of Pharmaceutical Sciences|August 1, 1990
Inhibitors of immune complex-induced inflammation: 5-substituted 3-[1-(2-benzoxazolyl)hydrazino]propanenitrile derivativesK H Kim, Y C Martin, P R Young, et al.
International Journal of Immunopharmacology|February 1, 1995
Clinical activity of leukotriene inhibitorsR R Harris, G W Carter, R L Bell, et al.
Pageof 8